Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study
Abstract Background Basal cell adenoma (BCA) and basal cell adenocarcinoma (BCAC) are benign and malignant, basaloid salivary gland neoplasms, respectively. These tumors show a dual-cell proliferation of inner luminal/ductal cells and outer abluminal/myoepithelial or basal cells. The only difference...
Main Authors: | Yuzo Oyama, Haruto Nishida, Takahiro Kusaba, Hiroko Kadowaki, Motoki Arakane, Junpei Wada, Shogo Urabe, Takashi Hirano, Kenji Kawano, Masashi Suzuki, Shigeo Yokoyama, Tsutomu Daa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-018-0726-8 |
Similar Items
-
Clinicopathological evaluation of radiation induced basal cell carcinoma
by: Meibodi Naser, et al.
Published: (2008-01-01) -
Metastatic basal cell carcinoma
by: Isha Shah, et al.
Published: (2021-01-01) -
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011-12-01) -
ADVANCED STAGE OF FACIAL BASAL CELL CARCINOMA
by: Muhammad Sharjeel
Published: (2018-12-01) -
A Case of Primary Cutaneous Basal Cell Carcinosarcoma
by: Hiromi Suzuki, et al.
Published: (2018-08-01)